BioCentury
ARTICLE | Finance

DOD takes on Ebola

AVI, Tekmira receive DoD contracts to develop Ebola treatments

July 26, 2010 7:00 AM UTC

HHS isn't the only U.S. government agency providing funding to small cap biotechs. AVI BioPharma Inc. (NASDAQ:AVII) and Tekmira Pharmaceuticals Corp. (TSX:TKM), recently won significant contracts from the Department of Defense.

Both contracts are part of the Transformational Medical Technologies (TMT) program, which focuses on platform-based biodefense programs...